| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |